市場調査レポート

商品コード

乳幼児・子供・母親のプロバイオティクスサプリメントの2028年までの市場予測-形態（カプセルとソフトジェル、グミ、液体、その他）とエンドユーザー（乳幼児、子供、母性女性）別の世界分析

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

出版日: 2022年07月30日 | 発行: The Insight Partners

| ページ情報: 英文 130 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 714,987円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,029,267円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,343,547円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

乳幼児・子供・母親のプロバイオティクスサプリメント市場は、2021年の6億494万米ドルから2028年には10億8170万米ドルに達すると予測されます。2022年から2028年にかけてはCAGR8.7%で成長すると予測されています。

プロバイオティクスは、消化器系の健康を促進し、人間の腸内環境の改善に役立つ生きた微生物です。免疫システムを強化することで病気の発生を防ぐため、予防医療において重要な役割を担っています。腸の健康は、消費者の間で最も重要な健康問題の一つになっています。プロバイオティクスの利点に関する意識の高まりは、乳児、子供、妊産婦の健康サプリメントでその人気を急上昇させました。これらの要因は、世界中でこれらのサプリメントの需要を大幅に推進しています。子供たちの間で不健康な消費習慣に起因する消化器系疾患の有病率が上昇しています。この要因は、乳児、子供、母親のプロバイオティクスサプリメント市場に強い可能性を提供します。

最終用途に基づいて、乳幼児・子供・母親のプロバイオティクスサプリメント市場は、乳幼児、子供、母親の女性に分類されます。2020年には、子供セグメントが最大の市場シェアを占めています。しかし、妊産婦セグメントは予測期間中に最も高いCAGRを記録すると予想されます。

プロバイオティクスサプリメントは、赤ちゃんの湿疹リスクの低減、出産に伴う合併症の軽減、妊産婦の代謝の健康増進などの役割を果たすことから、妊産婦の間で人気を集めています。妊娠中の女性は、腸内細菌叢の変化を含め、生理機能や免疫系に劇的な変化を経験します。これらの問題は、プロバイオティクスサプリメントを使用して対処することができます。プロバイオティクスサプリメントは、妊婦の体重増加を助ける。

地域別に見ると、乳幼児・子供・母親のプロバイオティクスサプリメント市場は、北米、欧州、アジア太平洋地域（APAC）、世界のその他の地域（RoW）に区分されます。2020年には、北米が最大の市場シェアを占めています。アジア太平洋地域は、予測期間中に最も速いCAGRを記録すると推定されます。北米の優位性は、乳児、子供、妊婦のためのプロバイオティクスサプリメントの利点に関する消費者の意識の高まりに起因しています。この地域の親は、彼らの子供の発達と成長をより懸念しています。

この地域で観察される一般的な健康状態には、アレルギー、喘息、尿路感染症、乳児の疝痛、自閉症などがあります。喘息のアレルギー・喘息財団によると、2018年には、米国で約5,200人の子供が季節性アレルギー性鼻炎と診断されました。子供たちの健康問題の増加は、親たちを不安にさせ、その結果、プロバイオティクスサプリメントの取り込みが高まっています。

さらに、北米諸国の政府は、乳幼児と子供の健康を向上させるためのイニシアチブを取っています。例えば、ヘルシー・スタートは、小児医療を改善するための取り組みの一つです。このイニシアチブは、この地域の乳幼児死亡率を下げ、出生前の健康を向上させることを目的としています。したがって、プロバイオティクスサプリメントの出生前と出生後の使用は、さらに北米全体で、乳児、子供、母親のプロバイオティクスサプリメント市場の成長を急増しています。

乳幼児、子供、および母親のプロバイオティクスサプリメント市場で動作する主要なプレーヤーは、バイエル社、ネスレSA、マミーズブリス株式会社、ラブバグプロバイオティクス、バイオガイアAB、メリアルースオーガニックス、LLC、ファーマバイトLLC、エボルブバイオシステムズ、バイオメロジー、および北欧ナチュラルを含んでいます。これらの企業は、世界中で拡大する消費者の需要に応えるため、新製品の発売や地域的な拡大に注力しています。

乳児、子供、母親のプロバイオティクスサプリメントの全体的な市場規模は、一次情報と二次情報の両方を使用して導き出されています。調査プロセスを開始するにあたり、市場に関連する質的・量的情報を入手するため、内外の情報源を用いて徹底的な二次調査を実施しました。また、データを検証し、テーマについてより分析的な洞察を得るために、業界関係者に複数の一次インタビューを実施しました。このプロセスの参加者は、VP、事業開発マネージャー、市場情報マネージャー、国内販売マネージャーなどの業界専門家や、乳児、子供、母親のプロバイオティクスサプリメント市場を専門とする評価専門家、調査アナリスト、キーオピニオンリーダーなどの外部コンサルタントです。

市場促進要因
- 小児栄養におけるプロバイオティクスサプリメントの需要増加
- 妊婦のプロバイオティクスサプリメントの利点に関する意識の高まり
市場抑制要因
- 新生児用プロバイオティクスサプリメントに対する消費者の認識
市場機会
- 発展途上地域での需要の急増
今後の動向
- 乳児用および母体用プロバイオティクス分野における研究開発の増加
推進要因と抑制要因の影響分析

第6章乳幼児・子供・母親のプロバイオティクスサプリメント-世界市場分析

乳幼児・子供・母親のプロバイオティクスサプリメント市場の概要
競合の位置づけ-主要市場プレイヤー

第7章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- フォーム別

乳幼児・子供・母親のプロバイオティクスサプリメント市場、形態別（2021年、2028年）
カプセルとソフトジェル
グミ
液体
その他

第8章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- エンドユーザー別

乳幼児・子供・母親のプロバイオティクスサプリメント市場、エンドユーザー別（2021年、2028年）
乳幼児・幼児
小児
母子家庭の女性

第9章乳幼児・子供・母親のプロバイオティクスサプリメント市場- 地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- ロシア
- その他欧州
アジア太平洋地域
- 中国
- 日本
- オーストラリア
- ニュージーランド
- その他アジア太平洋地域
世界のその他の地域
- 中南米
- 中東とアフリカ

第10章業界の情勢

製品の発売
事業拡大

第11章 COVID-19のパンデミックが乳幼児・子供・母親のプロバイオティクスサプリメント市場に与える影響

COVID-19の乳幼児・子供・母親のプロバイオティクスサプリメント市場への影響
北米
欧州 COVID-19のパンデミック別影響評価
アジア太平洋地域
中東・アフリカ
中南米

第12章企業プロファイル

Bayer Corporation
MaryRuth Organics, LLC
Mommy's Bliss Inc.
Pharmavite LLC
Nestle S.A.
BioGaia AB
Evolve Biosystems
Lovebug Probiotics
Biomeology
Nordic Naturals

第13章付録

The Insight Partners について
単語索引

図表

List Of Tables

Table 1. Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
Table 2. Global Infant, Child, And Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Global Infant, Child, And Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 4. North America Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 5. North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 6. US Infant, Child, and Maternal Probiotic Supplements Market, Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 7. US Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Canada Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Canada Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Mexico Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Germany Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Germany Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 16. UK Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 17. UK Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 18. France Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 19. France Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Italy Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 21. Italy Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Russia Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Russia Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 26. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 28. China Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 29. China Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 30. Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 31. Japan Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 32. Australia Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 33. Australia Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 34. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 35. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 36. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 37. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 38. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 39. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 40. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 41. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 42. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 43. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 44. List of Abbreviation

List Of Figures

Figure 1. Infant, Child, and Maternal Probiotic Supplements Market Segmentation
Figure 2. Infant, Child, and Maternal Probiotic Supplements Market Segmentation - By Geography
Figure 3. Global Infant, Child, and Maternal Probiotic Supplements Market Overview
Figure 4. Infant, Child, and Maternal Probiotic Supplements Market: By Form
Figure 5. Infant, Child, and Maternal Probiotic Supplements Market: By Region
Figure 6. Global Infant, Child, and Maternal Probiotic Supplements Market, Key Market Players
Figure 7. Porter's Five Forces Analysis: Infant, Child, and Maternal Probiotic Supplements Market
Figure 8. Expert Opinion
Figure 9. Ecosystem: Infant, Child, and Maternal Probiotic Supplements Market
Figure 10. Infant Mortality Rate: The US, 2010-2020
Figure 11. Global Infant, Child, and Maternal Probiotic Supplements Market Impact Analysis of Drivers and Restraints
Figure 12. Geographic Overview of Infant, Child, and Maternal Probiotic Supplements Market
Figure 13. Global: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 14. Key Players: Infant, Child, and Maternal Probiotic Supplements Market
Figure 15. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 16. Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 17. Gummies: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 18. Liquid: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 19. Others: Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast To 2028 (US$ Thousand)
Figure 20. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By End User (2021 and 2028)
Figure 21. Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 22. Children: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 23. Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 24. Global Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Region (2021 and 2028)
Figure 25. North America: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 27. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 28. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 29. US: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Canada: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Mexico: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 34. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 35. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 36. Germany: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 37. UK: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 38. France: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 39. Italy: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 40. Russia: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 41. Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 42. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)
Figure 43. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2021 and 2028)
Figure 44. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 45. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 46. China: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 47. Japan: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 48. Australia: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 49. New Zealand: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 50. Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 51. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)
Figure 52. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2020 and 2028)
Figure 53. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 54. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Region (2021 and 2028)
Figure 55. South and Central America: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 56. Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
Figure 57. Impact of COVID-19 Pandemic on North America Infant, Child, and Maternal Probiotic Supplements Market
Figure 58. Impact of COVID-19 Pandemic on Europe Infant, Child, and Maternal Probiotic Supplements Market
Figure 59. Impact of COVID-19 Pandemic on Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market
Figure 60. Impact of COVID-19 Pandemic on the Middle East & Africa Infant, Child, and Maternal Probiotic Supplements Market
Figure 61. Impact of COVID-19 Pandemic on South & Central America Infant, Child, and Maternal Probiotic Supplements Market

Product Code: TIPRE00029530

The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the demand for these supplements across the world. There is a rising prevalence of digestive disorders due to unhealthy consumption habits amongst children. This factor provides a strong potential to the infant, child, and maternal probiotic supplements market.

Based on end use, the infant, child, and maternal probiotic supplements market is segmented into infant and toddler, children, and maternal women. The children segment accounted for the largest market share in 2020. However, the maternal women segment is expected to register the highest CAGR during the forecast period.

Probiotic supplements are gaining popularity among pregnant women due to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women gain weight.

Based on region, the infant, child, and maternal probiotic supplements market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2020, North America held the largest market share. Asia Pacific is estimated to register the fastest CAGR over the forecast period. The dominance of North America is attributed to the increasing awareness among consumers about the benefits of probiotic supplements for infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth.

Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the rising uptake of probiotic supplements.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

The key players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy's Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are focusing on new product launches and geographical expansions to meet the growing consumer demand worldwide.

The overall infant, child, and maternal probiotic supplements market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders, specializing in the Infant, Child, and Maternal Probiotic Supplements Market.

Reasons to Buy:

Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global infant, child, and maternal probiotic supplements market, thereby allowing players to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study
3.2 Research Methodology
- 3.2.1 Data Collection:
- 3.2.2 Primary Interviews:
- 3.2.3 Hypothesis Formulation:
- 3.2.4 Macro-economic Factor Analysis:
- 3.2.5 Developing Base Number:
- 3.2.6 Data Triangulation:
- 3.2.7 Country Level Data:
- 3.2.8 Limitations and Assumptions:

4. Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis

5. Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
- 5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
- 5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
- 5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
- 5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints

6. Infant, Child, and Maternal Probiotic Supplements - Global Market Analysis

6.1 Infant, Child, and Maternal Probiotic Supplements Market Overview
6.2 Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
6.3 Competitive Positioning - Key Market Players

7. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

7.1 Overview
7.2 Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
- 7.3.1 Overview
- 7.3.2 Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
- 7.4.1 Overview
- 7.4.2 Gummies: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
- 7.5.1 Overview
- 7.5.2 Liquid: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

8.1 Overview
8.2 Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
- 8.3.1 Overview
- 8.3.2 Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
- 8.4.1 Overview
- 8.4.2 Children: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
- 8.5.1 Overview
- 8.5.2 Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. Infant, Child, and Maternal Probiotic Supplements Market - Geographic Analysis

9.1 Overview
9.2 North America: Infant, Child, and Maternal Probiotic Supplements Market
- 9.2.1 North America: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.2 North America: Infant, Child, and Maternal Probiotic Supplements Market, By Form
- 9.2.3 North America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
- 9.2.4 North America: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.2.4.1 US: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.2.4.1.1 US: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.2.4.1.2 US: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.2.4.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.2.4.2.1 Canada: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.2.4.2.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.2.4.3 Mexico: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.2.4.3.1 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.2.4.3.2 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market
- 9.3.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
- 9.3.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
- 9.3.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
- 9.3.4 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.3.4.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.3.4.2 UK: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.3.4.3 France: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.3.4.4 Italy: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.3.4.5 Russia: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.3.4.6 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.3.4.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.3.4.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market
- 9.4.1 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
- 9.4.2 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
- 9.4.3 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
- 9.4.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.4.4.1 China: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.4.4.1.1 China: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.4.4.1.2 China: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.4.4.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.4.4.2.1 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.4.4.2.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.4.4.3 Australia: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.4.4.3.1 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.4.4.3.2 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.4.4.4 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.4.4.4.1 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.4.4.4.2 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.4.4.5 Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.4.4.5.1 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.4.4.5.2 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market
- 9.5.1 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
- 9.5.2 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Form
- 9.5.3 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by End User
- 9.5.4 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Key Region
  - 9.5.4.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.5.4.1.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.5.4.1.2 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.5.4.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    - 9.5.4.2.1 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    - 9.5.4.2.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview
10.2 Product launch
10.3 Expansion

11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

11.1 Impact of COVID-19 on Infant, Child, and Maternal Probiotic Supplements Market
11.2 North America: Impact Assessment of COVID-19 Pandemic
11.3 Europe Impact Assessment of COVID-19 Pandemic
11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.6 South & Central America: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

12.1 Bayer Corporation
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 MaryRuth Organics, LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Mommy's Bliss Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pharmavite LLC
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Nestle S.A.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BioGaia AB
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Evolve Biosystems
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Lovebug Probiotics
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Biomeology
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Nordic Naturals
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Word Index

乳幼児・子供・母親のプロバイオティクスサプリメントの2028年までの市場予測-形態（カプセルとソフトジェル、グミ、液体、その他）とエンドユーザー（乳幼児、子供、母性女性）別の世界分析

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

目次

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章乳幼児・子供・母親のプロバイオティクスサプリメント市場情勢

第5章乳幼児・子供・母親のプロバイオティクスサプリメント市場- 主要な市場力学

第6章乳幼児・子供・母親のプロバイオティクスサプリメント-世界市場分析

第7章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- フォーム別

第8章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- エンドユーザー別

第9章乳幼児・子供・母親のプロバイオティクスサプリメント市場- 地域別分析

第10章業界の情勢

第11章 COVID-19のパンデミックが乳幼児・子供・母親のプロバイオティクスサプリメント市場に与える影響

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Infant, Child, and Maternal Probiotic Supplements Market Landscape

5. Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

6. Infant, Child, and Maternal Probiotic Supplements - Global Market Analysis

7. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

8. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

9. Infant, Child, and Maternal Probiotic Supplements Market - Geographic Analysis

10. Industry Landscape

11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

12. COMPANY PROFILES

13. Appendix

乳幼児・子供・母親のプロバイオティクスサプリメントの2028年までの市場予測-形態（カプセルとソフトジェル、グミ、液体、その他）とエンドユーザー（乳幼児、子供、母性女性）別の世界分析

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

第4章 乳幼児・子供・母親のプロバイオティクスサプリメント市場情勢

第5章 乳幼児・子供・母親のプロバイオティクスサプリメント市場- 主要な市場力学

第6章 乳幼児・子供・母親のプロバイオティクスサプリメント-世界市場分析

第7章 乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- フォーム別

第8章 乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- エンドユーザー別

第9章 乳幼児・子供・母親のプロバイオティクスサプリメント市場- 地域別分析

第10章 業界の情勢

第11章 COVID-19のパンデミックが乳幼児・子供・母親のプロバイオティクスサプリメント市場に与える影響

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Infant, Child, and Maternal Probiotic Supplements Market Landscape

5. Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

6. Infant, Child, and Maternal Probiotic Supplements - Global Market Analysis

7. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

8. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

9. Infant, Child, and Maternal Probiotic Supplements Market - Geographic Analysis

10. Industry Landscape

11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

12. COMPANY PROFILES

13. Appendix

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章乳幼児・子供・母親のプロバイオティクスサプリメント市場情勢

第5章乳幼児・子供・母親のプロバイオティクスサプリメント市場- 主要な市場力学

第6章乳幼児・子供・母親のプロバイオティクスサプリメント-世界市場分析

第7章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- フォーム別

第8章乳幼児・子供・母親のプロバイオティクスサプリメント市場分析- エンドユーザー別

第9章乳幼児・子供・母親のプロバイオティクスサプリメント市場- 地域別分析

第10章業界の情勢

第12章企業プロファイル

第13章付録